4471 — Sanyo Chemical Industries Balance Sheet
0.000.00%
- ¥89bn
- ¥72bn
- ¥142bn
- 78
- 88
- 70
- 94
Annual balance sheet for Sanyo Chemical Industries, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 23,647 | 18,171 | 17,114 | 27,240 | 24,532 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 41,481 | 46,323 | 45,779 | 44,975 | 34,720 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 89,340 | 93,764 | 97,324 | 105,929 | 84,942 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 61,255 | 61,389 | 59,791 | 51,477 | 46,142 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 195,723 | 200,194 | 202,182 | 205,818 | 176,366 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 46,222 | 47,904 | 46,938 | 53,519 | 30,332 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 55,249 | 55,714 | 56,115 | 66,781 | 40,981 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 140,474 | 144,480 | 146,067 | 139,037 | 135,385 |
| Total Liabilities & Shareholders' Equity | 195,723 | 200,194 | 202,182 | 205,818 | 176,366 |
| Total Common Shares Outstanding |